The Recall Desk
SevereFDA (Drugs)·D-0370-2021·Announced 2021-05-12

QMart Recalls Burro en Primavera Capsules for Unapproved Ingredients

QMart is recalling Burro en Primavera capsules because FDA analysis found unapproved tadalafil and/or sildenafil.

What this means for you

Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.

Our severity reasoning: The recall is classified as FDA Class II, which corresponds to a Severe severity score under the rubric.

Plain-English summary

QMart is recalling 500 boxes of Burro en Primavera, 2 capsules (UPC 638632431055). The product was distributed nationwide in the United States.

The recall was initiated because the product was marketed without an approved New Drug Application (NDA) or Abbreviated New Drug Application (ANDA). FDA analysis results indicated the presence of tadalafil and/or sildenafil in the product.

Consumers who have purchased this product should stop using it and contact QMart for further instructions.

The recalled product

Product
Burro en Primavera, 2 capsules, UPC 638632431055
Manufacturer
QMart
Affected units
500

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (1)

  • All

Distribution

Distributed nationwide across the United States.

Part of a larger recall action

This product is one of 4 recalled by QMart under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.

See all 4 products in this recall →